Skip to main content
Promino Nutritional Sciences Inc. logo

Promino Nutritional Sciences Inc. — Investor Relations & Filings

Ticker · MUSL CSE Manufacturing
Open in API
Filings indexed 217 across all filing types
Latest filing 2025-11-25 Regulatory Filings
Country CA Canada
Listing CSE MUSL

About Promino Nutritional Sciences Inc.

https://drinkpromino.com/

Promino Nutritional Sciences Inc. is a research-driven nutraceutical company specializing in the development and distribution of science-based, clinically proven nutritional products for muscle health and recovery. The company focuses on patented formulations of essential amino acids (EAAs) designed to optimize muscle protein synthesis (MPS). Its flagship product, Promino™, is a consumer supplement that delivers a precise ratio and potency of all nine EAAs, demonstrated to be significantly more effective than traditional protein sources like whey. Promino's products target athletes and individuals seeking metabolic health improvements. The company also explores clinical applications, such as retaining muscle mass in cancer patients undergoing chemotherapy.

Recent filings

Filing Released Lang Actions
ON form 13-502F1 (class 1 and 3B reporting issuers - participation fee).PDF
Regulatory Filings Classification · 1% confidence The document is a Form 13-502F1, which is a regulatory filing required by the Ontario Securities Commission (OSC) for reporting issuers to calculate and pay their participation fees based on market capitalization. Since this is a specific regulatory form for fee calculation and does not fit into categories like financial reports, earnings releases, or management reports, it falls under the 'Regulatory Filings' (RNS) category as the appropriate fallback.
2025-11-25 English
News release - English.pdf
Capital/Financing Update Classification · 1% confidence The document is a 'Pricing Supplement' for Bank of Montreal's 'AutoCallable Barrier Notes'. It details the specific terms, risks, and financial structure of a structured product offering. This type of document is a formal regulatory filing related to the issuance of securities (capital/financing) and does not fit into the categories of annual reports, earnings releases, or simple announcements. It is a core document for a capital market offering.
2025-11-20 English
News release - English.pdf
Regulatory Filings Classification · 1% confidence The document is a press release announcing that the company has filed corrective disclosures with the Ontario Securities Commission (OSC) regarding its MD&A and executive compensation. It describes the nature of the regulatory review and points to the SEDAR+ platform where the actual filings can be found. Since this is an announcement about the filing of reports rather than the reports themselves, and it pertains to regulatory compliance and corrective actions, it fits best as a Regulatory Filing (RNS).
2025-11-20 English
52-109F1R - Certification of refiled annual filings - CFO (E).pdf
Audit Report / Information Classification · 1% confidence The document is a 'Form 52-109F1R', which is a regulatory certification form used in Canada for refiled annual filings. It is a legal attestation by the CFO regarding the accuracy of financial statements and MD&A. Since it is a specific regulatory filing required by securities legislation and does not fit into the categories of a full annual report, earnings release, or management report, it is best classified as a Regulatory Filing (RNS). FY 2024
2025-11-19 English
52-109F1R - Certification of refiled annual filings - CEO (E).pdf
Regulatory Filings Classification · 1% confidence The document is a 'Form 52-109F1R', which is a regulatory certification form used in Canada for the refiling of annual filings. It contains the CEO's certification regarding the accuracy and fair presentation of the company's annual financial statements and MD&A. Since it is a regulatory certification document rather than the financial report itself, and it does not fit into the specific categories like 10-K or IR, it falls under the 'Regulatory Filings' (RNS) category as a fallback for miscellaneous regulatory compliance documents.
2025-11-19 English
Annual MD&A (amended) - English.pdf
Management Reports Classification · 1% confidence The document is an 'Amended Management's Discussion and Analysis' (MD&A) for Promino Nutritional Sciences Inc. for the years ended December 31, 2024 and 2023. It provides a detailed review of the company's financial condition, business operations, product descriptions, and forward-looking statements. This document is a core component of the company's annual financial reporting package, specifically the management's narrative analysis of the financial results.
2025-11-19 English

Report missing filing

Can't find a specific document? Let us know and we'll add it within 24 hours.

We will notify you once the filing is added.
Report sent
Thank you. We will check the data and update it shortly.